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Is There Any Specificity to Defects of Anchoring Fibrils in 
Epidermolysis Bullosa Dystrophica, and What Does This Mean in Terms 
of Pathogenesis? 
In this issue Tidman and Eady [1] report t hat anchoring 
fib rils are tota lly absent in severe generalized ep idermolysis 
b ullosa dystrophica- recessive (EBD-R) ~nd din:inished ~n num-
ber in both more loca lized EBD-R a nd m domma nt epidermo-
lys is bullosa dystrophica (EBD) using a controlled ultr~~truc­
t ura l morphometric technique. No qualitative abnormalities ?f 
anchoring fibrils (AF) were detected in t he latter ~1seases. Th1s 
a r ticle focuses atte nt ion aga in on the role of AF 1n EBD. The 
purpose of t his editorial is to consider t he specificity of possible 
AF defects in various forms of EBD and comment on the 
meaning of t hese findin gs in the pathogenesis of t hese disor-
ders. 
AF are small filamentous structures located on the dermal 
s ide of t he la mina densa at t he epidermal-dermal junction. The 
cent ral port ion of t he AF is cross-banded and, in some prope_rly 
o riented AF, this cross-banding pattern resembles t he bandmg 
pattern of co llagens, but is not identical ~o any prevwusly 
isolated collage n type. At e1ther end, tine filamentous arrays 
extend from t he cent ral ba nded area. The distal (adepidermal) 
ends inse rt directly into t he lamina densa. Proximally, t he 
fibr ils loop in to t he dermis and eit her connect w_ith other A_F 
for ming a subla mina densa network, or te rmmate 111 t he derm1s 
without apparent connection to spec ific dermal structures, es-
pec ially collagen fibers or dermal microfibril bundles. Recent 
ultrastructural morphometric studies of normal ep idermal-der-
mal junction indicate that AF numbers vary s i gnifican~ly be-
tween normal individuals and among different body regwns of 
t he same individual [2]. Variat ions in s ize and morphology of 
AF were apparent in t hese studies and enhance t he difficulty 
of assessment. 
The biochemical compos it ion of AF is not known. Although 
a nchoring fibri l-lamina densa complexes have been isolat~d 
[3], t he yields from these preparations are very low and s1gm f-
icant contamination of AF with lamina densa and dermal 
co llagen limit their usefuln ess for analys is. The c~n_t:a i cr_oss-
banded patte rn referred to above and the susceptibili ty of AF 
to bacterial (clostridial) collage nase suggest t hat AF are collag-
e nous in natu re. Recently, Burgeson a nd his associates isolated 
a new collagen from placenta te rmed Type VII coll agen that 
featured an unusually long alpha chain length [4]. Segmental 
long-space crystalli tes produced by polymerizat ion ? f T~e VII 
collagen yielded a ba nding pattern very similar or 1dent1cal to 
the banding pattern of AF. These studies indicate that at least 
a portion of AF may be composed of Type VII coll agen. 
Two murine monoclonal ant ibodies (AF-1 and AF-2) were 
recently reported [5,6]. Both of these antibodies reacted with 
human skin base ment membrane zone and the basement mem-
b rane area of other human tissues known to contain AF. 
Immunoelectron microscopy demonstrated localization of AF-
1 and AF-2 to t he area immediately subjacent to lamina densa, 
a lt hough a somewhat different distribut ion of immune_ re~c­
tants were present wit h t he two ant ibodies. AF-1 was d!stnb-
u ted in the lower portion of the lamina densa and in t he area 
immediately beneath the lamina densa, on and near AF. The 
reaction product assoc iated with AF -2 was more disc reet and 
localized in t he a rea below the lam ina densa associated wit h 
AF. This localization suggested t hat the two ant ibodies recog-
nized different epitopes associated wi th AF. 
STRUCTURAL LESIONS IN EPIDERMOLYSIS 
BULLOSA DYSTROPHICA 
The group of inheri ted mechanobullous di seases, collectively 
termed epidermolysis bullosa dystrophica, a ll feature dys-
trophic scarring a nd blister formation with the level of sepa-
ration below t he lamina densa. Autosomal recessive and auto-
somal dominant types of EBD were recognized early. Further 
heterogeneity probably ex ists within t hese genetic subgroups. 
Recessive epidermolysis bullosa dystrophica has been subdi -
vided clinically based on severity, extent of disease, and distri-
but ion , and include t he following subtypes: severe generalized 
EBD-R (gravis) , more mild generalized disease (mitis), local-
ized, and inverse types. These distinctions are somewhat arbi-
trary but EBD-R is clearly heterogeneous from t he clinical 
standpoint. In general, t hese subtypes breed truly within a 
kindred [7], suggesting that they may represent genetic heter-
ogeneity, a lthough multiple a llelic variants at a single ge ne 
locus is also possible. 
The most characteristic form of EBD-R is t he generalized, 
severe (gravis) type. This disease begins at or soon after birt h 
and affects any area of the cutaneous surface as well as strati-
fied squamous epithelia of the mouth, esophagus, a nd anal 
canal. Severe dystrophic scarring leads to a variety of compli -
cations including mittenlike encasements of t he hands and feet, 
joint contractures, and esophageal and anal strictures. 
The ultrastructural pat hologic lesion in severe generalized 
EBD-R has been addressed by several investigators with gen-
eral agreement t hat the level of separation is in t he dermis 
beneath t he lamina densa (dermolytic). Experimental blisters 
can be induced with ease in t his disease and confirm t his level 
of separation. Collagen degeneration (collagenolysis) is variable 
from minimal to absent in t he unblistered skin to extensive in 
blistered areas [8]. However, some difference of opinion has 
evolved among various investigators concerning t he presence 
or absence of AF in this disease. Briggaman and Wheeler 
reported the absence of AF in t he nonblistered and never 
previously blistered skin of patients with ep idermolysis bullosa 
of the severe generalized type [9]. Subsequent ly, Hashimoto et 
a[ reported some patients wit h generalized EBD-R that showed 
normal AF although t here was moderate to marked reduction 
of AF in most patients [10]. Hanna eta! recently reported the 
absence of AF in 6 patients with generali zed EBD-R [11] . In 
none of these studies was cont rolled systematic quantitation 
undertaken . The repo rt by Tidman and Eady [1) undertakes 
such a study and shows t hat AF were totally absent in 7 patients 
with generalized severe EBD-R. These studies indicate t hat t he 
complete absence of AF in t his form of EBD-R represents a 
specific structural abnormality. It is not possible to account for 
t he discrepancies in t he Hashimoto study and t hose in which 
total absence of AF was found, however t he finding of occa-
sional patients with t hi s disease in whom AF are present cannot 
be discounted. Genetic heterogeneity may ex ist within this 
group. More patients with t his disease will need to be studied 
with t he detailed ul t rastructural morphometric procedures of 
Tidman and Eady to clarify t his issue. The weight of evidence 
indicates t hat t he absence of AF is a specific structural defect 




A recent study using monoclonal antibodies to AF (AF-1 and 
AF -2) showed an absence of reactivity to the AF antibodies in 
severe generali zed EBD-R in both unblistered skin and exper-
imentally blistered skin examined by both immunofluorescent 
and immunoelectron microscopic procedures [6]. This study 
confirms the ul trastructural observation of absence of AF in 
this disease. 
Fine et al recently described a mouse monoclonal antibody 
(KF -l) that identifies a previously unrecognized, collagenase-
res istant antigen located in the lamina densa and that is also 
absent in the clinically uninvolved skin of patients with EBD-
R [12]. The relationship of this antibody and the lamina densa 
antigen it recognizes to the AF defects described above is 
unknown, but it could be speculated that these antibodies (KF-
1, AF-1, AF-2) identify different ep itopes within the same 
anchoring fibril-lamina densa complex. 
Localized forms of EBD-R present a more heterogeneous 
group . Autosomal recessive inheritance can be documented in 
these patients although sporadic cases may be indistinguishable 
from dominant EBD and indeed may represent that disease in 
some cases. Clinically, t he disease is usually localized to areas 
of maximal trauma, part icularly the hands, feet, elbows, and 
knees, although other areas may be involved, particularly early 
in life. Lesions heal with dystrophic scars. 
Ultrastructurally, minimal to marked decrease in number of 
AF was initially reported by Hashimoto et a] [10] . This has 
also been our experience with these patients. Tidman and Eady 
in their morphometric studies confirm the reduction in AF 
numbers in these patients. No specific qualitative AF abnor-
malit ies were noted by any of the investigating groups. The 
number of carefully studied patients remains small so that 
further work is also necessary in this form. 
Autosomal dominant epidermolysis bullosa dystrophica 
(EBD-D) is classically divided into two groups of patients, the 
albopapuloid type (Pasini) and the hyperplastic type (Cock-
ayne-Touraine). Both diseases feature blistering at sites of 
maximal t rauma, particularly the arms, legs, hands, and feet, 
followed by dystrophic scarring at the sites. Beyond the pres-
ence of t he albopapuloid lesions, these two diseases are difficult 
to distinguish clinically. Specific ultrastructural differences 
have been reported for the 2 diseases, alt hough both produce 
dermolytic sublamina densa separation. In the albopapu loid 
type, AF were reported to be qualitatively abnormal and re-
duced in number in both blister-prone and nonblister-prone 
skin [13,14]. In hyperplastic EBD-D, AF are diminished in 
number and/o r abnormal only in the bliste r-prone areas, but 
not in uninvolved areas [15). The morphometric study by 
Tidman and Eady confirms a decrease in AF numbers but did 
not. recognize a qualitat ive abnormality of the AF or clearly 
distinguish an ultrastructural difference between patients with 
and without albopapuloid lesions. The specificity of the ultra -
structural defects in dominant dystrophic EB are uncertain at 
lhis time. The previously noted variability in AF size and 
morphology as well as numbers in different individuals and 
body regions make assessment difficult and points out the need 
for careful ultras tructural morphometric analysis in these de-
fects. 
PATHOGENESIS OF EPIDERMOLYSIS BULLOSA 
DYSTROPHICA 
Significant advances have been made in understanding the 
pathogenic mechanisms of EBD -R. Evidence has accrued that 
excessive proteolytic activity of human skin coll agenase may 
destroy sublamina densa elements responsible for epidermal-
dermal adherence. Following the obsevation of collagenolysis 
in t he early ultrastructural studies [8], increased human skin 
collagenase activity was demonstrated in the skin of EBD-R 
patients as well as other types of epidermolysis bullosa, espe-
cially in the bli stered skin 116]. Later, immunoreactive coll a-
genase protein (enzyme) was found to be increased in vivo in 
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blistered and nonblistered skin (17) . Enhanced synthesis of 
immunoreactive collagenase by cultured skin fibroblasts was 
demonstrated specifically in patients with EBD-R [18,19]. In 
patients with severe generalized EBD-R, aberrant mutant en-
zymes were identified that had diminished affinity for their 
metal cofactor calcium and marked thermolabi lity [20,21). In 
addition, evidence for abnormalities in the control of enzyme 
regulation were found [21,22) . Abnormalities of human skin 
collagenase have not been specifically correlated with different 
types of EBD-R, but apparently all types may demonstrate this 
abnormality. Nevertheless, some evidence for genetic hetero-
geneity in EBD-R exists regarding the human skin collagenase 
abnormality [18,21,22]. 
What structures of the dermis and epidermal-dermal junction 
are attacked by human skin collagenase? Human skin collagen-
ase cleaves both type I and type III collagen, the predominant 
types of the human dermis. Type IV collagen, which is present 
in the lamina densa, is not a substrate for human skin colla-
genase. It is not known whether AF are attacked by human 
skin collagenase or not, but type VII collagen does not appear 
to be cleaved by human skin collagenase (H. W elgus, personal 
communication) . The morphologic observation of collageno-
lysis with sparing of the lamina densa would be consistent with 
the known biochemical substrates for human skin collagenase. 
The absence or marked diminution of AF in EBD-R remains 
unexplained. The actual presence of type VII collagen in skin 
AF remains unproven so that cleavage of AF by human skin 
collagenase is not excluded. It may also be speculated that AF 
may be more complex and composed of both collagenous and 
noncollagenous proteins. In addition, unrecognized connections 
may exist between AF and type I or type III coll agen. In any 
event t he relationship of the abnormali ties of human skin 
collagenase and AF to the pathogenesis of EBD-R remains 
unsolved. 
Previous recombinant graft studies using normal and EBD-
R skin components show that AF do not reform when EBD-R 
dermis is a component of t he graft [9]. Although these studies 
raise the possibility of faulty formation of AF as a possible 
mechanism for di sease, these observations cou ld be explained 
on the basis of human skin collagenase produced by t he abnor-
mal EBD-R dermis which destroys or inhibits t he formation of 
AF. The studies do indicate that the abnormal EBD-R de.rmis 
is somehow involved in t he pathogenesis. 
Ehrlich and his colleagues, in a recent series of articles, have 
shown that EBD-R fibroblasts exhibit aberrant cell behavior 
in culture compared to normal fibroblasts [23-25]. When grown 
in a co llagen lattice, the EBD-R fibroblasts assume a more 
rounded, dendritic appearance, fail to spread out and elongate, 
and do not contract the collagen lattice as normal fibroblasts 
do. The mechanism of t his defect was related to enhanced 
synthesis of prostaglandin Ez (PGE2) by the EBD-R fibrob lasts. 
PGE2 in turn stimulated adenylate cyclase activity thereby 
increased cAMP levels. F -actin distribution was abnormal in 
the cytoskeleton of t he EBD-R fibroblasts, probably as a result 
of the increased cyclic AMP levels, which is known to alter 
cytoskeletal elements within the cel l. Indomethacin, an inhib-
itor of prostaglandin synthesis, reversed the defect. In the 
presence of indomethacin, lattice contraction, cell elongation 
and spreading, and cytoskeletal morphology of EBD-R fibro-
blasts were similar to normal human fibroblasts. The relation-
sh ip of these aberrant cell function activities of the EBD-R 
fibroblasts to the pathogenesis of the disease is not clear. 
Production of collagenase and prostaglandins by isolated ad-
herent rheumatoid synovial cells has been reported previously 
and suggests a link between the aberrant fibroblasts behavior 
and human skin collagenase production by the EBD-R fibro-
blasts. 
In dominant EBD, the explanation of the pathogenesis by 
primary AF defect is attractive and in keeping with primary 
structural protein abnormalities in dominant inherited dis-
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e a ses. H owever, the study by Tidman and Eady cited prev iously 
r a ises questions concerning the spec ificity of t he AF defect in 
domina nt EBD . 
R ecent ly, an abnorma li ty in t he glycosaminoglyca n (GAG) 
m etaboli sm in the a lbopapuloid type of EBD-D was reported 
(2 6]. Increased amoun ts of chrondroit in sulfates were prese nt 
in the skin and increased leve ls were a lso found in the urine. 
Increased sy nt hesis of sulfated GAGs by cul tured skin fibro-
blasts from these patients were a lso demonstrated. The GAGs 
w e re present both in cells and excreted in t he media. The defect 
was limi ted to t he synt hesis of sulfated GAGs since degradation 
was normal. H ow t hi s defect spec ifically correlates with t he 
m orph ologic AF abnorma li t ies and t ranslates into decreased 
d e rma l-epide rmal adherence remains unclear . 
Robert A. Brigga man , M.D. 
U nivers ity of Nort h Carolina at Chapel Hill 
and Nort h Carolina Memoria l H ospita l 
Chapel Hill , North Carolina 
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